Effective Communication Can Bridge Gaps in Care | APhA 2025
Drug Topics
MARCH 21, 2025
Sally Arif, PharmD, professor in the College of Pharmacy at Midwestern University, discusses how pharmacists can effectively communicate with diverse patients.
Fri.Mar 21, 2025
499 
How pharma could feel the pain of a recession
PharmaVoice
MARCH 21, 2025
Pharma has long been considered “recession proof,” but an economic downturn could still hurt the industry in numerous ways.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Pharmacists’ Expertise in Contraceptive Counseling Amid Ongoing Challenges | APhA 2025
Drug Topics
MARCH 21, 2025
Jasmine Cutler, PharmD, discussed the unique expertise pharmacists possess in order to counsel patients seeking any type of contraceptive product.
APhA 2025: Pharmacists Can Prescribe Contraceptives in 30 States and the District of Columbia
Pharmacy Times
MARCH 21, 2025
Contraceptive options have expanded since 1960, with pharmacists today playing a growing role as prescribers of contraception and studies showing the benefit of pharmacist-driven contraception clinics.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Expert Discusses Navigating Anticoagulation in Older Adults | APhA 2025
Drug Topics
MARCH 21, 2025
Elizabeth Pogge, PharmD, professor in the College of Pharmacy at Midwestern University, discusses initiating anticoagulation for older adults as well as the risk-benefit balance of the therapy.
BCMA-Targeting CAR T-Cell Therapy Is Feasible in Patients With Multiple Myeloma and CNS Involvement
Pharmacy Times
MARCH 21, 2025
Patients with central nervous system (CNS) involvement achieved favorable outcomes with chimeric antigen receptor (CAR) T-cell therapy.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Heart Failure With Improved Ejection Fraction Is a Rising Focus in Cardiovascular Care
Pharmacy Times
MARCH 21, 2025
This subset of heart failure requires unique therapeutic considerations.
OTC Analgesic Toxicity Common Among Children
Drug Topics
MARCH 21, 2025
According to poison control data, many children aged 0 to 17 experience toxicity from over-the-counter analgesics like ibuprofen and acetaminophen.
Nipocalimab Is Granted Fast Track Designation for Treatment of Patients With Sjögren’s Disease
Pharmacy Times
MARCH 21, 2025
Sjgren's disease is one of the most common chronic autoimmune diseases that affects 4 million individuals around the world.
Q&A: Pharmacists’ Role in GLP-1 Diet, Exercise Counseling
Drug Topics
MARCH 21, 2025
Lydia Newsom, PharmD, discuses how pharmacists can support patients using GLP-1s.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing
The Guardian - Pharmaceutical Industry
MARCH 21, 2025
Pharmaceutical company will invest money over five years in strategic partnership with the citys authorities Business live latest updates AstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detentions of top executives in China.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 21, 2025
During interviews at HIMSS, healthcare executives shared their thoughts on the evolution of AI with a big focus on scaling the technology, integrating with existing systems and gaining adoption.
Elevated Non-HDL Cholesterol a Stronger Indicator of Major Cardiovascular Events Compared With LDL-C
Pharmacy Times
MARCH 21, 2025
Non-high-density lipoprotein cholesterol was found to be more effective at predicting cardiovascular events such as stroke, myocardial outcomes, heart failure, and others compared with low-density lipoprotein cholesterol.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 21, 2025
Highly controversial firings at the Federal Trade Commission could lead to an unprecedented legal conundrum at the heart of an upcoming PBM insulin lawsuit.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
CDC Launches Study on Vaccine-Autism Link Amid Ongoing Measles Outbreak
Pharmacy Times
MARCH 21, 2025
The study aims to address lingering public concerns, but its findings and communication have the potential to impact vaccine confidence and public health efforts.
Alnylam joins three-way contest in ATTR cardiomyopathy
pharmaphorum
MARCH 21, 2025
Alnylam has claimed FDA approval for Amvuttra in ATTR cardiomyopathy, allowing it to compete with rival therapies from Pfizer and BridgeBio.
Bringing Better Health to the Navajo Nation
Pharmacy Times
MARCH 21, 2025
For two years in a row, McKesson has partnered with customers and industry partners to bring health education and awareness of resources to members of the Navajo community.
Fabhalta is first FDA-approved therapy for rare disease C3G
pharmaphorum
MARCH 21, 2025
Novartis' oral complement inhibitor Fabhalta has become the first approved treatment for rare kidney disease C3G as it chases a $3bn sales target
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Experts: Vast Disparities in Opioid Prescribing Observed for Minority Communities in Past Decade
Pharmacy Times
MARCH 21, 2025
Allison Ju-Chen Hu, PhD and Yuhua Bao, PhD describe results of their landmark study that found significant differences in opioid prescriptions in racially and ethnically minoritized communities.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 21, 2025
The former physician-lawmaker was an influential player in congressional health policy during his 20-plus years in the House. The White House has not yet named its next choice for the position after pulling the nomination of Dave Weldon, M.D., last week.
J&J boosts US operations with $55bn investment
Pharmaceutical Technology
MARCH 21, 2025
J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 21, 2025
As the Department of Government Efficiency (DOGE) looks to access an unprecedented amount of data housed by the Department of Health and Human Services and the rest of the federal government, privacy experts warn of DOGE's ever-growing influence.
Guselkumab Receives FDA Approval for Adults With Moderately to Severely Active Crohn Disease
Pharmacy Times
MARCH 21, 2025
The new indication for guselkumab in Crohn disease builds off a previous approval in ulcerative colitis, providing patients a treatment option for the major forms of inflammatory bowel disease.
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
Pharmaceutical Technology
MARCH 21, 2025
J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately to severely active Crohn's disease (CD) in adults.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 21, 2025
Aledade is expanding its value-based care relationship with Humana to bring the partnership's services to rural health clinics and federally qualified health centers.
Global funding cuts reversing decades of tuberculosis progress, WHO says
Pharmaceutical Technology
MARCH 21, 2025
Ahead of World Tuberculosis Day on 24 March, the WHO has said that global funding cuts are curtailing efforts to fight the disease.
APhA 2025: Strategies for Reducing Errors in Community Pharmacy Settings
Pharmacy Times
MARCH 21, 2025
Community pharmacies can enhance medication safety by proactively identifying risks and implementing targeted best practices.
Pharma is running out of names. Can an AI help?
pharmaphorum
MARCH 21, 2025
Pharma is running out of names. Can an AI help? Jonah.
APhA 2025: A Pharmacist’s Guide to Culturally Competent and Inclusive Care
Pharmacy Times
MARCH 21, 2025
Sally Arif, PharmD, BCCP, discusses her presentation on the critical role of pharmacists in addressing health disparities by improving communication, fostering cultural competence, and promoting pharmacoequity.
AZ builds in China, as J&J ramps up its US investments
pharmaphorum
MARCH 21, 2025
AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.
APhA 2025: Nakia Eldridge, PharmD, MBA, Highlights Must-See Sessions
Pharmacy Times
MARCH 21, 2025
Nakia Eldridge, PharmD, MBA, shares insights for health system and community pharmacists attending the 2025 APhA Annual Meeting & Exposition.
EMA panel endorses AI for MASH clinical trials
pharmaphorum
MARCH 21, 2025
PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.
Despite New Agents in SCLC, Prolonged Survival Remains an Unmet Need
Pharmacy Times
MARCH 21, 2025
After decades without improvements, an expert with Baptist Health described the small cell lung cancer (SCLC) space as exciting following multiple innovations in the past few years.
Let's personalize your content